Human poisoning by organophosphates bearing two methoxy groups, e.g. by mal
athion, paraoxon-methyl, dimethoate and oxydemeton-methyl, is generally con
sidered to be rather resistant to oxime therapy. Since the oxime effectiven
ess is influenced not only by its reactivating potential but also by inhibi
tion, aging and spontaneous reactivation kinetics, experiments were perform
ed with human acetyl- (AChE) and butyrylcholinesterase (BChE) to determine
the respective kinetic constants. The efficacy of obidoxime in reactivating
dimethylphosphoryl-AChE was 40, 9 and 3 times higher than of HI 6, pralido
xime and HLo 7, respectively. Aging (t(1/2) 3.7 h) and spontaneous reactiva
tion (t(1/2) 0.7 h) occurred concomitantly, with the portion of the aged en
zyme being dependent on the presence of excess inhibitor. Calculation of st
eady-state AChE activity in the presence of inhibitor and oxime revealed th
at obidoxime was superior to pralidoxime. In addition, organophosphate conc
entrations up to 10(-6) M (paraoxon-methyl) and 10(-4) M (oxydemeton-methyl
) could be counteracted at clinically relevant oxime concentrations (10 mu
M). These data indicate that oximes may effectively reactivate human dimeth
ylphosphoryl-AChE. Failure of oximes may be attributed to megadose intoxica
tions and to prolonged time intervals between poison uptake and oxime admin
istration. The potency of the oximes to reactivate dimethylphosphoryl-BChE
was much lower and the spontaneous reactivation slower (t1/2 9 h), while ag
ing proceeded at a comparable rate. Thus, BChE activity determination for d
iagnosis and therapeutic monitoring may give no reliable information on ACh
E status.